Merck Applies for Covid Pill Approval in Japan, Nikkei Reports
2021年12月3日 - 4:16PM
Dow Jones News
--Merck & Co.'s Japan unit applied for approval of its
Covid-19 pill in the country, local business daily Nikkei reported
Friday, citing unnamed sources.
--If approved by the government, Merck plans to distribute the
pill in Japan as early as later this month, the Nikkei report
said.
Full story: https://s.nikkei.com/3DjwETO (Japanese)
Write to Kosaku Narioka at kosaku.narioka@wsj.com
(END) Dow Jones Newswires
December 03, 2021 02:01 ET (07:01 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Merck (NYSE:MRK)
過去 株価チャート
から 3 2024 まで 4 2024
Merck (NYSE:MRK)
過去 株価チャート
から 4 2023 まで 4 2024
